Fortescue Ltd
FMG
National Australia Bank Ltd
NAB
BHP Group Ltd
BHP
ANZ Group Holdings Ltd
ANZ
CommBank
CBA
AU Stock MarketDetailed Quotes
RGT Argent Biopharma Ltd
- 0.245
- -0.005-2.00%
20min DelayNot Open Jan 8 15:54 AET
13.30MMarket Cap-0.52P/E (Static)
0.280High0.220Low362.25KVolume0.250Open0.250Pre Close90.30KTurnover0.57052wk High3.70%Turnover Ratio54.27MShares0.15052wk Low-0.474EPS TTM2.40MFloat Cap0.570Historical HighLossP/E (Static)9.79MShs Float0.150Historical Low-0.474EPS LYR24.00%Amplitude--Dividend TTM-2.58P/B1Lot Size--Div YieldTTM
Argent Biopharma Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | -155.29%-1.14M | -3.74%2.06M | -20.78%2.14M | 295.09%2.7M | 12.45%-1.38M | -142.29%-1.58M | -642.08%-651.81K | 175.72%120.24K | -29.40%-158.81K | -29.76%-122.73K |
| Revenue from customers | -64.68%1.4M | -37.92%3.96M | 194.89%6.38M | 4.37%2.16M | 110.34%2.07M | 228.93%985.2K | 149.09%299.51K | 3,597.48%120.24K | --3.25K | ---- |
| Income from government grants | 397.32%6K | -410.46%-2.02K | --650 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other cash income from operating activities | -33.74%-2.54M | 55.20%-1.9M | -893.59%-4.24M | 115.47%534.53K | -34.72%-3.45M | -169.57%-2.56M | ---951.32K | ---- | -32.05%-162.06K | -20.70%-122.73K |
| Cash paid | 4.88%-13.12M | 3.33%-13.79M | 2.84%-14.27M | -73.76%-14.69M | -72.32%-8.45M | 8.39%-4.91M | -9.92%-5.35M | -57.35%-4.87M | -518.13%-3.1M | -32.45%-500.87K |
| Payments to suppliers for goods and services | 4.88%-13.12M | 3.33%-13.79M | 2.84%-14.27M | -73.76%-14.69M | -72.32%-8.45M | 8.39%-4.91M | -9.92%-5.35M | -57.35%-4.87M | -518.13%-3.1M | -32.45%-500.87K |
| Direct interest paid | 98.81%-3.06K | -911.29%-257.4K | -244.05%-25.45K | 94.54%-7.4K | -30,436.49%-135.58K | 99.08%-444 | -51.48%-48.24K | -170.43%-31.85K | ---11.78K | ---- |
| Direct interest received | ---- | -20.27%240 | -96.23%301 | -43.94%7.98K | -91.00%14.24K | -5.82%158.19K | 32.00%167.98K | 176.11%127.26K | 683.04%46.09K | --5.89K |
| Direct tax refund paid | ---- | ---- | ---- | ---- | ---- | ---27.32K | ---- | ---- | ---- | ---- |
| Operating cash flow | -18.90%-14.26M | 1.35%-11.99M | -1.41%-12.16M | -20.42%-11.99M | -56.70%-9.96M | -7.94%-6.35M | -26.44%-5.89M | -44.57%-4.66M | -421.36%-3.22M | -30.67%-617.71K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -123.12%-140.12K | 154.55%606.2K | 25.61%-1.11M | -54.02%-1.49M | -2.41%-969.88K | -178.07%-947.04K | 46.05%-340.58K | 3.03%-631.23K | -105.74%-650.94K | 37.70%-316.4K |
| Capital expenditure reported | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 49.62%-159.4K | 37.70%-316.4K |
| Net PPE purchase and sale | 26.20%-140.12K | 92.95%-189.87K | -207.31%-2.69M | 8.39%-876.36K | -153.72%-956.63K | -10.71%-377.04K | 69.90%-340.58K | -1,178.12%-1.13M | ---88.52K | ---- |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---33.42K | ---- |
| Net business purchase and sale | ---- | ---- | 98.78%-4.55K | -2,716.55%-373.25K | 97.68%-13.25K | ---569.99K | ---- | -99.91%124 | --142.57K | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | --302.82K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other investing changes | ---- | -49.82%796.07K | 390.03%1.59M | ---547K | ---- | ---- | ---- | 197.62%500K | ---512.17K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -123.12%-140.12K | 154.55%606.2K | 25.61%-1.11M | -54.02%-1.49M | -2.41%-969.88K | -178.07%-947.04K | 46.05%-340.58K | 3.03%-631.23K | -105.74%-650.94K | 37.70%-316.4K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 52.74%14.87M | -0.05%9.73M | -42.89%9.74M | 62.98%17.05M | 38,627.72%10.46M | -99.43%27.01K | -46.64%4.7M | -22.26%8.81M | 1,359.40%11.33M | -45.19%776.56K |
| Net issuance payments of debt | ---- | 11,563.92%7.16M | -98.93%61.42K | --5.75M | ---- | ---- | ---- | -224.22%-1M | --805K | ---- |
| Net common stock issuance | 445.48%15.1M | -72.14%2.77M | -14.00%9.94M | 1.08%11.56M | 42,223.21%11.43M | -99.43%27.01K | -52.08%4.7M | -6.82%9.81M | 1,255.73%10.53M | -45.19%776.56K |
| Net other financing activities | -18.77%-238.68K | 23.59%-200.96K | -2.74%-263.01K | 73.64%-255.99K | ---971.29K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 52.74%14.87M | -0.05%9.73M | -42.89%9.74M | 62.98%17.05M | 38,627.72%10.46M | -99.43%27.01K | -46.64%4.7M | -22.26%8.81M | 1,359.40%11.33M | -45.19%776.56K |
| Net cash flow | ||||||||||
| Beginning cash position | -87.29%239.82K | -65.28%1.89M | 190.02%5.43M | -20.42%1.87M | -76.12%2.35M | -13.24%9.86M | 43.93%11.36M | 1,706.82%7.9M | -26.57%436.99K | 268.63%595.09K |
| Current changes in cash | 128.00%463.71K | 53.11%-1.66M | -198.99%-3.53M | 867.49%3.57M | 93.61%-464.85K | -376.42%-7.27M | -143.34%-1.53M | -52.79%3.52M | 4,836.29%7.46M | -136.11%-157.54K |
| Effect of exchange rate changes | -106.95%-658 | 161.86%9.46K | -96.14%-15.3K | 50.85%-7.8K | 93.12%-15.87K | -1,152.14%-230.66K | 140.34%21.92K | -1,654.60%-54.34K | -452.05%-3.1K | 78.88%-561 |
| End cash Position | 193.08%702.87K | -87.29%239.82K | -65.28%1.89M | 190.02%5.43M | -20.42%1.87M | -76.12%2.35M | -13.24%9.86M | 43.93%11.36M | 1,706.82%7.9M | -26.57%436.99K |
| Free cash from | -18.20%-14.4M | 17.96%-12.18M | 3.04%-14.85M | -40.28%-15.32M | -62.57%-10.92M | -5.83%-6.72M | -9.66%-6.35M | -65.26%-5.79M | -274.89%-3.5M | 4.74%-934.1K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |